You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 26 No. 3, March 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (126)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Depression and MHPG Excretion

Response to Dextroamphetamine and Tricyclic Antidepressants

Jan Fawcett, MD; James W. Maas, MD; Haroutune Dekirmenjian, PhD

Arch Gen Psychiatry. 1972;26(3):246-251.


Abstract

A study of 12 depressed inpatients shows a significant correlation of improvement with both double-blind administration of dextroamphetamine sulfate and tricyclic antidepressant drug treatment and the low mean baseline excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG). The mean MHPG excretion for six patients with a good response to dextroamphetamine was found to be significantly lower than the mean MHPG level for six nonresponders. Five of six responders showed a slight increase in MHPG excretion with dextroamphetamine while five of six nonresponders showed a modest decrease in MHPG excretion. A correlation coefficient between low mean baseline MHPG excretion and improvement in depression ratings reached .58 (P < .50) for the third week and .84 (P < .01) for the fourth week of tricyclic drug therapy. These findings are discussed in terms of the catecholamine depletion hypothesis of depression and the problem of the prediction of response to tricyclic antidepressant therapy.



Author Affiliations

Chicago

From the Illinois State Psychiatric Institute (Drs. Fawcett, Maas, and Dekirmenjian), and the Department of Psychiatry, Abraham Lincoln School of Medicine (Drs. Fawcett and Maas), Chicago.


Footnotes

Accepted for publication Sept 9, 1971.

Reprint requests to Illinois State Psychiatric Institute, 1601 W Taylor St, Chicago 60612 (Dr. Fawcett).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Afternoon Continuous Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol and Age: Distinctive Biologic Subgroups of Endogenous Depression?
Halbreich et al.
Arch Gen Psychiatry 1987;44:804-812.
ABSTRACT  

Urinary 3-Methoxy-4-Hydroxyphenylglycol and Major Affective Disorders: A Replication and New Findings
Muscettola et al.
Arch Gen Psychiatry 1984;41:337-342.
ABSTRACT  

Treatment of Depression
Jones
JAMA 1983;250:2286-2286.
ABSTRACT  

Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG)
Keeton et al.
Science 1981;211:586-588.
ABSTRACT  

Dextroamphetamine: Its Cognitive and Behavioral Effects in Normal and Hyperactive Boys and Normal Men
Rapoport et al.
Arch Gen Psychiatry 1980;37:933-943.
ABSTRACT  

Urinary MHPG Levels and Tricyclic Antidepressant Drug Selection: A Preliminary Communication on Improved Drug Selection in Clinical Practice
Cobbin et al.
Arch Gen Psychiatry 1979;36:1111-1115.
ABSTRACT  

Clinical and Biochemical Heterogeneity of Depressive Disorders
MAAS
ANN INTERN MED 1978;88:556-563.
ABSTRACT  

CNS Monoamine Metabolism in Bipolar Affective Disorder: Evaluation Using a Peripheral Decarboxylase Inhibitor
Garfinkel et al.
Arch Gen Psychiatry 1977;34:735-739.
ABSTRACT  

Reduced Growth Hormone Responses to Amphetamine in "Endogenous" Depressive Patients: Studies in Normal, "Reactive" and "Endogenous" Depressive, Schizophrenic, and Chronic Alcoholic Subjects
Langer et al.
Arch Gen Psychiatry 1976;33:1471-1475.
ABSTRACT  

Prediction of Tricyclic Antidepressant Response: A Critical Review
Bielski and Friedel
Arch Gen Psychiatry 1976;33:1479-1489.
ABSTRACT  

Biogenic Amines and Depression: Biochemical and Pharmacological Separation of Two Types of Depression
Maas and Maas
Arch Gen Psychiatry 1975;32:1357-1361.
ABSTRACT  

Strain differences during intraventricular infusion of norepinephrine: possible role of receptor sensitivity
Segal et al.
Science 1975;189:301-303.
ABSTRACT  

Overview of Recent Research in Depression: Integration of Ten Conceptual Models Into a Comprehensive Clinical Frame
Akiskal and McKinney
Arch Gen Psychiatry 1975;32:285-305.
ABSTRACT  

Antidepressant Response to Tricyclics and Urinary MHPG in Unipolar Patients: Clinical Response to Imipramine or Amitriptyline
Beckmann and Goodwin
Arch Gen Psychiatry 1975;32:17-21.
ABSTRACT  

Depressive Disorders: Toward a Unified Hypothesis: Clinical, experimental, genetic, biochemical, and neurophysiological data are integrated
Akiskal and McKinney
Science 1973;182:20-29.
ABSTRACT  

Relation of Exercise to MHPG Excretion in Normal Subjects
Goode et al.
Arch Gen Psychiatry 1973;29:391-396.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.